Decker Weiss, NMD, FASA
En los prximos aos, es previsible que el manejo farmacolgico de la obesidad evolucione hacia modelos ms individualizados en los que, ms all del porcentaje de prdida de peso, el xito de una estrategia teraputica radique en la mejora de la composicin corporal, la funcionalidad fsica, la prevencin de la fragilidad y la restauracin de la calidad de vida, imprescindible en una enfermedad crnica
Secondly, weight changes are an important therapeutic outcome and potential indicator of treatment response, especially when GLP-1 agonists are prescribed for weight management
It is supplied in 8 mL vials and injected into the subcutaneous fat layer using a fine-gauge needle or cannula
By doing so, they can help patients use semaglutide effectively while minimizing the risk of liver-related issues
Singh D, Chaudhary D, Kumar V, Verma A (2021) Amelioration of diethylnitrosamine (DEN) induced renal oxidative stress and inflammation by Carissa carandas embedded silver nanoparticles in rodents
